Cargando…
Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
Probiotic bacteria have many protective effects against inflammatory disorders, though the mechanisms underlying their actions are poorly understood. The Lab4b consortium of probiotics contains four strains of lactic acid bacteria and bifidobacteria that are reflective of the gut of newborn babies a...
Autores principales: | O’Morain, Victoria L., Chen, Jing, Plummer, Sue F., Michael, Daryn R., Ramji, Dipak P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964490/ https://www.ncbi.nlm.nih.gov/pubmed/36835055 http://dx.doi.org/10.3390/ijms24043639 |
Ejemplares similares
-
The Lab4P Consortium of Probiotics Attenuates Atherosclerosis in LDL Receptor Deficient Mice Fed a High Fat Diet and Causes Plaque Stabilization by Inhibiting Inflammation and Several Pro‐Atherogenic Processes
por: O'Morain, Victoria L., et al.
Publicado: (2021) -
Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high fat diet
por: Moss, Joe W. E., et al.
Publicado: (2021) -
A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro
por: Moss, Joe W. E., et al.
Publicado: (2016) -
Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
por: Michael, D. R., et al.
Publicado: (2021) -
The Impact of Lab4 Probiotic Supplementation in a 90-Day Study in Wistar Rats
por: Webberley, Thomas S., et al.
Publicado: (2021)